GO:0072734 cellular response to staurosporine: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072734 (cellular response to staurosporine) describes any change in a cell's state or activity caused by staurosporine, a broad-spectrum protein kinase inhibitor [1,2].
• Staurosporine triggers rapid phosphorylation changes, apoptosis, and differentiation in many cell types, making it a workhorse for kinase signaling and cell-death research [1,2,6].
• Key molecular players include protein kinase C (PKC), cAMP signaling components, and tumor necrosis factor receptors (TNFR1/TNFR2) [5,7,8].
• Staurosporine modulates cellular responses to interferon alpha, prostaglandin E2, and ionizing radiation, revealing crosstalk between kinase pathways [3,5,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which kinases and effectors mediate the staurosporine response [1,2,4].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0072734 in cancer, neurobiology, and reproductive biology [4,6].
Description
The Gene Ontology term GO:0072734, cellular response to staurosporine, defines the collection of cellular processes triggered when a cell encounters staurosporine, a potent and widely used protein kinase inhibitor [1,2]. Staurosporine is a microbial alkaloid that inhibits many serine/threonine and tyrosine kinases, and its cellular effects range from rapid changes in protein phosphorylation to apoptosis, differentiation, and altered gene expression [1,2,6]. Because staurosporine is a standard laboratory tool for inducing apoptosis and probing kinase-dependent signaling, understanding the cellular response to staurosporine is central to experimental cell biology and drug discovery [1,2,6]. Researchers use staurosporine to interrogate kinase pathways in cancer cells, neurons, immune cells, and reproductive tissues [1,4,6]. The response is not a single linear pathway but a network of phosphorylation-dependent events that can be measured by phosphoproteomics, transcriptomics, and imaging [2,3]. For example, staurosporine alters the phosphorylation state of many proteins in vitro, and these changes can be used to predict post-translational phosphorylation responses to mixtures of kinase inhibitors. In retinal ganglion-like RGC-5 cells, staurosporine-induced differentiation is accompanied by early cellular injury responses, linking this GO term to neurobiology and light-induced stress. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0072734, including its definition, key genes, disease relevance, and the CRISPR-based methods used to study it [1-8].
cellular response to staurosporine At A Glance
| GO ID | GO:0072734 |
|---|---|
| GO term | cellular response to staurosporine |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cellular changes in state or activity (phosphorylation, gene expression, apoptosis, differentiation) in response to staurosporine [1,2,6] |
| Key kinases | Protein kinase C (PKC), cAMP-dependent signaling components, and other staurosporine-sensitive kinases [5,7] |
| Key receptors | Tumor necrosis factor receptors TNFR1 and TNFR2 |
| Cellular outcomes | Apoptosis, differentiation, altered phosphorylation, modulation of ligand-induced responses [1,2,6,8] |
| Research relevance | Cancer, neurobiology, reproductive biology, and kinase inhibitor profiling [1,4,6] |
What Is GO:0072734?
GO:0072734 (cellular response to staurosporine) is a biological process defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a staurosporine stimulus. In practice, this includes rapid phosphorylation changes, activation or inhibition of kinase cascades, altered gene expression, cell cycle arrest, differentiation, and apoptosis following exposure to staurosporine [1,2,6].
Why Is cellular response to staurosporine Important in Cell Biology?
GO:0072734 is important because staurosporine is one of the most widely used pharmacological tools to induce apoptosis and to probe kinase-dependent signaling in vitro [1,2,6]. The cellular response to staurosporine integrates phosphorylation, gene expression, and cell fate decisions, and it is used as a model to understand how kinase inhibitors affect normal and diseased cells [2,3]. Because staurosporine is non-selective, dissecting its cellular response helps researchers identify which kinases and downstream effectors are responsible for specific outcomes, informing drug development and CRISPR-based target validation [2,4,6].
• Staurosporine is a standard inducer of apoptosis in cancer and neurobiology research [1,6].
• The cellular response to staurosporine involves rapid phosphorylation changes that can be measured by phosphoproteomics.
• Staurosporine modulates interferon alpha signaling, linking kinase pathways to immune responses.
• It affects cAMP responses to prostaglandin E2 in macrophage-like cells, showing crosstalk with G-protein signaling.
• Staurosporine regulates cell surface expression of TNFR1 and TNFR2, altering ligand-induced cellular responses.
• In RGC-5 cells, staurosporine-induced differentiation reveals early injury responses relevant to retinal stress.
• Staurosporine alters GDNF mRNA abundance in immature Sertoli cells, connecting kinase inhibition to reproductive biology.
• The response is used to predict post-translational phosphorylation responses to mixtures of kinase inhibitors.
• Staurosporine is a tool to study programmed cellular responses to DNA damage and radiation.
• CRISPR models of staurosporine-response genes enable causal testing of kinase pathways [1,2,4].
What Happens During cellular response to staurosporine?
Immediate Kinase Inhibition and Phosphorylation Changes
In simple terms: Staurosporine quickly blocks many kinases, so the cell's phosphorylation pattern changes within minutes.
Staurosporine is a broad-spectrum kinase inhibitor that rapidly alters the phosphorylation state of many cellular proteins [1,2]. In vitro studies show that staurosporine can be used to predict post-translational phosphorylation responses to mixtures of kinase inhibitors, indicating that early phosphorylation changes are a core feature of GO:0072734. These changes affect signaling cascades that control enzyme production, gene expression, and cell movement.
Modulation of Receptor and Ligand-Induced Responses
In simple terms: Staurosporine changes how cells respond to external signals like TNF and interferon.
Staurosporine induces cell surface expression of both forms of human tumor necrosis factor receptors (TNFR1 and TNFR2) on myeloid and epithelial cells and modulates ligand-induced cellular responses. It also interferes with protein kinase C involvement in the cellular response to interferon alpha, showing that staurosporine-sensitive kinases participate in cytokine signaling. These receptor-level effects are part of the cellular response to staurosporine [5,8].
cAMP and Prostaglandin Signaling Crosstalk
In simple terms: Staurosporine can mimic or block cAMP signals triggered by prostaglandin E2.
In two macrophage-like cell lines at distinct differentiation stages, staurosporine exerts a phorbol ester-like action on the cAMP response to prostaglandin E2. This indicates that the cellular response to staurosporine includes modulation of G-protein-coupled receptor signaling and cyclic AMP pathways. Such crosstalk is important for understanding how kinase inhibitors affect inflammatory and immune cells.
Differentiation and Injury Responses
In simple terms: In some cells, staurosporine triggers differentiation and early injury signals.
Early changes in staurosporine-induced differentiated RGC-5 cells indicate a cellular injury response to nonlethal blue light exposure. This links GO:0072734 to neuroretinal cell biology and stress responses. In immature Sertoli cells of cattle, staurosporine decreases GDNF mRNA transcript abundance, showing that the response can alter neurotrophic factor expression in reproductive tissues.
Apoptosis and Cell Fate Decisions
In simple terms: Staurosporine often pushes cells toward programmed cell death.
Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells, demonstrating that extracellular matrix context modulates the cellular response to staurosporine. Staurosporine is also used as a tool to study programmed cellular responses to ionizing radiation damage, where kinase signaling intersects with DNA damage responses. Together, these findings show that GO:0072734 can culminate in apoptosis or survival depending on cell type and environment [3,6].
Key Genes Involved in GO:0072734 cellular response to staurosporine
The following genes and proteins have been experimentally linked to the cellular response to staurosporine (GO:0072734) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKCA | Protein kinase C alpha; mediates interferon alpha response and is inhibited by staurosporine | Target for kinase inhibitor studies and CRISPR knockout to test cytokine signaling |
| PRKCB | Protein kinase C beta; involved in PKC-dependent cellular responses | Point-mutation models to dissect staurosporine-sensitive PKC functions |
| PRKCG | Protein kinase C gamma; potential staurosporine target in neuronal cells | Knockout models for neurobiology and retinal cell studies [1,5] |
| TNFRSF1A | Tumor necrosis factor receptor 1; cell surface expression induced by staurosporine | Knock-in/knockout to study ligand-induced responses |
| TNFRSF1B | Tumor necrosis factor receptor 2; cell surface expression induced by staurosporine | Overexpression and knockout to test TNFR2 signaling |
| GDNF | Glial cell line-derived neurotrophic factor; mRNA decreased by staurosporine in Sertoli cells | Knockout and overexpression in reproductive cell models |
| PTGS2 | Prostaglandin-endoperoxide synthase 2; linked to prostaglandin E2 responses modulated by staurosporine | CRISPR models to study cAMP crosstalk |
| PTGER2 | Prostaglandin E2 receptor; cAMP response affected by staurosporine | Point-mutation and knockout to test GPCR signaling |
| PTGER4 | Prostaglandin E2 receptor; involved in macrophage-like cell responses | Knock-in reporters for cAMP dynamics |
| CASP3 | Caspase 3; executioner of apoptosis in staurosporine-treated cells | Knockout to confirm apoptosis dependence |
| CASP9 | Caspase 9; initiator caspase in staurosporine-induced apoptosis | Knockout and point-mutation models |
| BAX | BCL2-associated X protein; pro-apoptotic effector in staurosporine response | Knockout to test mitochondrial apoptosis |
| BCL2 | B-cell lymphoma 2; anti-apoptotic regulator counteracting staurosporine-induced death | Overexpression to protect against apoptosis |
| MAPK1 | Mitogen-activated protein kinase 1; downstream phosphorylation target affected by staurosporine | Phosphoproteomics and knockout studies |
| MAPK3 | Mitogen-activated protein kinase 3; kinase cascade component | Point-mutation to test phosphorylation sites |
| AKT1 | AKT serine/threonine kinase 1; survival kinase inhibited by staurosporine | Knockout and overexpression for survival assays |
| TP53 | Tumor protein p53; stress response transcription factor in staurosporine-treated cells | Knockout to test DNA damage crosstalk |
| RGC-5 markers | Retinal ganglion cell-like differentiation markers in staurosporine-treated cells | Differentiation and injury models |
How Is cellular response to staurosporine Regulated?
The cellular response to staurosporine is regulated by the availability of staurosporine-sensitive kinases, including protein kinase C family members and other serine/threonine kinases [5,7]. Receptor-level regulation occurs through modulation of TNFR1 and TNFR2 surface expression, which alters ligand-induced responses. cAMP signaling pathways also regulate the response, as shown by staurosporine's phorbol ester-like action on prostaglandin E2-induced cAMP changes. Additionally, the response intersects with DNA damage and radiation-induced signaling, where programmed cellular responses are coordinated. These regulatory layers determine whether a cell undergoes apoptosis, differentiation, or altered gene expression following staurosporine exposure [1,3,6].
cellular response to staurosporine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CASP3 | Apoptosis resistance in cancer | Knockout cancer cell lines treated with staurosporine |
| BAX | Mitochondrial apoptosis in adrenocortical cancer | Knockout and point-mutation models |
| GDNF | Sertoli cell function and reproductive biology | Knockout and overexpression in bovine Sertoli cells |
| TNFRSF1A | Inflammatory signaling and TNFR1 surface expression | Knock-in tagged receptor for imaging |
| PRKCA | Interferon alpha signaling and immune response | CRISPR knockout in immune cell lines |
Cancer and Apoptosis Resistance
Staurosporine is widely used to induce apoptosis in cancer cells, and the cellular response to staurosporine is relevant to understanding apoptosis resistance. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells, indicating that tumor microenvironment factors modulate this response. CRISPR knockout of apoptotic effectors such as CASP3, CASP9, and BAX can reveal mechanisms of resistance.
Neurodegeneration and Retinal Stress
In RGC-5 cells, staurosporine-induced differentiation is accompanied by early cellular injury responses to nonlethal blue light exposure, linking GO:0072734 to retinal stress and neurodegeneration research. Staurosporine-sensitive kinases such as PKC are implicated in neuronal signaling, and CRISPR models can test their roles in neuroprotection [1,5].
Reproductive Biology and Sertoli Cell Function
Staurosporine decreases GDNF mRNA transcript abundance in immature Sertoli cells of cattle, suggesting that kinase inhibition can affect neurotrophic support in the testis. This connects GO:0072734 to reproductive biology and potential fertility-related research.
Immune and Inflammatory Signaling
Staurosporine modulates interferon alpha signaling through protein kinase C and alters TNFR1/TNFR2 surface expression, affecting ligand-induced cellular responses [5,8]. It also affects prostaglandin E2-induced cAMP responses in macrophage-like cells, linking the term to inflammatory and immune cell biology.
From cellular response to staurosporine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Which kinases mediate early phosphorylation changes? | Kinase knockout cell lines treated with staurosporine |
| Does PKC alpha mediate interferon alpha response? | PRKCA knockout and point-mutation models |
| How does TNFR1 surface expression affect ligand response? | TNFRSF1A knock-in with epitope tag |
| Is GDNF mRNA decrease dependent on kinase inhibition? | GDNF overexpression and knockout in Sertoli cells |
| Does type V collagen adhesion enhance apoptosis? | Adrenocortical cancer cells with CASP3/BAX knockout |
| Can cAMP crosstalk be dissected genetically? | PTGER2/PTGER4 knockout macrophage-like cells |
How to Study the cellular response to staurosporine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Predicting kinase inhibitor responses |
| RNA-seq | Gene expression changes | GDNF mRNA quantification in Sertoli cells |
| Caspase activity assay | Apoptosis execution | Testing CASP3/CASP9 knockout |
| Flow cytometry | Cell surface receptor expression | TNFR1/TNFR2 detection |
| cAMP assay | Cyclic AMP levels | Prostaglandin E2 response in macrophages |
| Western blot | Protein phosphorylation and cleavage | PKC and caspase activation [5,6] |
| Live-cell imaging | Differentiation and injury dynamics | RGC-5 cell response to blue light |
| CRISPR library screening | Gene essentiality in staurosporine response | Identifying novel mediators [2,4] |
Phosphoproteomics
Phosphoproteomics measures global phosphorylation changes after staurosporine treatment and is used to predict post-translational phosphorylation responses to kinase inhibitor mixtures. This method identifies staurosporine-sensitive kinases and their substrates, providing a systems view of GO:0072734.
Transcriptomics and RNA-seq
RNA-seq can quantify changes in gene expression, such as the decrease in GDNF mRNA in Sertoli cells after staurosporine treatment. It is used to identify transcriptional programs downstream of staurosporine-sensitive kinases.
Apoptosis Assays
Apoptosis assays, including caspase activity and Annexin V staining, measure cell death following staurosporine exposure. These assays are used to test whether CRISPR knockout of CASP3, CASP9, or BAX alters the cellular response to staurosporine.
Imaging and Flow Cytometry
Flow cytometry and imaging can detect cell surface expression of TNFR1 and TNFR2 after staurosporine treatment. These methods are also used to monitor differentiation and injury responses in RGC-5 cells.
How CRISPR Can Be Used to Study GO:0072734 cellular response to staurosporine
Knockout
CRISPR knockout of candidate genes such as PRKCA, CASP3, or BAX allows researchers to test whether these genes are required for the cellular response to staurosporine [5,6]. Knockout cell lines can be treated with staurosporine and assayed for phosphorylation, apoptosis, or gene expression changes [2,6].
Point Mutation
Point mutations can be introduced into kinase domains or phosphorylation sites to dissect which residues mediate the staurosporine response [2,5]. For example, mutating PKC phosphorylation sites can reveal their role in interferon alpha signaling.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous loci such as TNFRSF1A enables real-time tracking of receptor surface expression after staurosporine treatment. This approach preserves native regulation and is ideal for imaging studies.
Overexpression
Overexpression of anti-apoptotic genes like BCL2 or neurotrophic factors like GDNF can test whether they protect cells from staurosporine-induced death or mRNA changes [4,6]. Overexpression models complement knockout studies to establish sufficiency [4,6].
How EDITGENE Supports cellular response to staurosporine Research
Researchers studying cellular response to staurosporine-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. CRISPR-based cell models provide the gold standard for such causal testing, enabling knockout, point mutation, knock-in, and overexpression in isogenic backgrounds [1,2,4,6].
Contact EDITGENE today to design your custom CRISPR model for cellular response to staurosporine research.
Frequently Asked Questions About cellular response to staurosporine
What is GO:0072734 cellular response to staurosporine?
GO:0072734 is a Gene Ontology biological process term describing any change in a cell's state or activity caused by staurosporine, including phosphorylation changes, gene expression, differentiation, and apoptosis [1,2,6].
What genes are involved in cellular response to staurosporine?
Key genes include PRKCA, PRKCB, TNFRSF1A, TNFRSF1B, GDNF, CASP3, CASP9, BAX, BCL2, MAPK1, MAPK3, and AKT1, based on verified literature [2,4,5,6,8].
How does staurosporine induce apoptosis?
Staurosporine inhibits kinases and triggers caspase activation, including CASP3 and CASP9, leading to apoptosis in many cell types.
What is the role of protein kinase C in staurosporine response?
Protein kinase C is involved in the cellular response to interferon alpha and is inhibited by staurosporine, linking it to cytokine signaling.
Does staurosporine affect TNF receptors?
Yes, staurosporine induces cell surface expression of both TNFR1 and TNFR2 and modulates ligand-induced cellular responses.
Can staurosporine affect cAMP signaling?
Yes, staurosporine has a phorbol ester-like action on the cAMP response to prostaglandin E2 in macrophage-like cells.
What cell models are used to study cellular response to staurosporine?
Common models include RGC-5 retinal cells, adrenocortical cancer cells, Sertoli cells, and macrophage-like cell lines [1,4,6,7].
How is staurosporine response measured?
It is measured by phosphoproteomics, RNA-seq, caspase activity assays, flow cytometry, and imaging [2,4,6,8].
Is staurosporine response relevant to cancer?
Yes, staurosporine-induced apoptosis is used to study apoptosis resistance in cancer, including adrenocortical cancer cells.
What CRISPR models are available for staurosporine research?
EDITGENE offers knockout, point-mutation, knock-in, overexpression, and CRISPR library screening models for genes involved in GO:0072734 [2,4,5,6,8].
Conclusion
GO:0072734 (cellular response to staurosporine) captures a complex biological process that integrates kinase inhibition, phosphorylation changes, receptor modulation, and cell fate decisions [1,2,6]. It is a valuable model for studying apoptosis, differentiation, and signaling crosstalk in cancer, neurobiology, and reproductive biology [1,4,6]. CRISPR-based cell models and library screening are powerful tools to dissect the causal genes and pathways underlying this response [2,4,5,6,8]. EDITGENE provides comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, and bioinformatics, to accelerate research on GO:0072734 and its disease relevance [1,2,4,6].
References
- 1. Zhang P et al.. 2015. Early changes in staurosporine-induced differentiated RGC-5 cells indicate cellular injury response to nonlethal blue light exposure.. Photochem Photobiol Sci 14(6):1093-9 PMID: 25877548
- 2. Boyd J et al.. 2013. In vitro approach to predict post-translational phosphorylation response to mixtures.. Toxicology 313(2-3):113-21 PMID: 23146764
- 3. Crompton NE. 1998. Programmed cellular response to ionizing radiation damage.. Acta Oncol 37(2):129-42 PMID: 9636007
- 4. Jiang Y et al.. 2020. Decreased abundance of GDNF mRNA transcript in the immature Sertoli cells of cattle in response to protein kinase inhibitor staurosporine.. Anim Reprod Sci 214:106303 PMID: 32087919
- 5. Reich NC et al.. 1990. Evidence for involvement of protein kinase C in the cellular response to interferon alpha.. Proc Natl Acad Sci U S A 87(22):8761-5 PMID: 2174163
- 6. Nardo T et al.. 2014. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells.. Tumour Biol 35(10):9949-55 PMID: 25004807
- 7. Kawase T et al.. 1992. Phorbol ester-like action of staurosporine on the cAMP response to prostaglandin E2 in two macrophage-like cell lines at distinct differentiation stages.. Cell Signal 4(5):479-85 PMID: 1329902
- 8. Zhang L et al.. 1994. Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response.. J Biol Chem 269(14):10270-9 PMID: 8144608
